Antioxidant vitamins in the prevention of cardiovascular disease: A systematic review

Journal of Internal Medicine

Volumn 251, Issue 5, 2002, Pages 372-392

  Asplund, K ^a,b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Council on Technology Assessment in Health Care   (Sweden)

Author keywords

Antioxidant vitamins; Ascorbic acid; Cardiovascular disease; Carotene; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; LIPID; VITAMIN;

ARTERY WALL; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; HEART INFARCTION; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STROKE; SURVIVAL RATE; VITAMIN BLOOD LEVEL;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; HUMANS; LIPID PEROXIDATION; RANDOMIZED CONTROLLED TRIALS; VITAMINS;

EID: 0036098488     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00973.x     Document Type: Review

References (153)

1. Vitamin C intake and mortality among a sample of the United States population
2. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices
3. Does consumption of fruit and vegetables protect against stroke?
4. Vitamin C and blood pressure
5. Fruit and vegetable consumption and cardiovascular mortality
6. Dietary habits and mortality in 11 000 vegetarians and health conscious people: Results of a 17 year follow up
7. Legume consumption and risk of coronary heart disease in US men and women
8. Protective effect of fruits and vegetables on development of stroke in men
9. High fruit intake may reduce mortality among middle-aged and elderly men. The study of men born in 1913
10. Antioxidant status, erythrocyte fatty acids, and mortality from cardiovascular diseases
11. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease
12. Diet and coronary heart disease: Beyond dietary fats and low-density-lipoprotein cholesterol
13. Effect of risk factors values on lifetime risk of and age at first coronary event
14. Frequent nut consumption and risk of coronary heart disease in women: Prospective cohort study
15. Does diet or alcohol explain the French paradox?
16. Cross-sectional study of effects of drinking green tea on cardiovascular and liver diseases
17. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study
18. Vitamin E and coronary heart disease: The European paradox
19. Vitamin E and other essential antioxidants regarding coronary heart disease: Risk assessment studies. Epidemiological basis of the antioxidant hypothesis of cardiovascular disease
20. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology
21. Do hydroxy-carotenoids prevent coronary heart disease? A comparison between Belfast and Toulouse
22. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: Concomitant cross-sectional study of men aged 50
23. Could antioxidants play a role in high rates of coronary heart disease in the Czech Republic?
24. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 years: The EVA study
25. Dietary antioxidants and carotid artery wall thickness. The atherosclerosis risk in communities study
26. Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL
27. The Scottish heart health study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre
28. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects
29. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: A prospective population study
30. Oxidants and antioxidants in atherosclerosis
31. Oxidative modification of LDL and atherogenesis
32. No effect of β-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesteroaemic, postmenopausal women
33. Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation
34. Effects of diet and lifestyle changes on atherosclerotic risk factors after 24 weeks in the Indian diet heart study
35. Relationship between serum lipid peroxidation products in hypercholesterolemic subjects and vitamin E status
36. Oxidized LDL and antioxidants
37. Effect of combined supplementation with α-tocopherol, ascorbate, and β-carotene on low-density lipoprotein oxidation
38. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
39. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q and d-alpha-tocopherol in mildly hypercholesterolemic subjects: A randomized placebo-controlled clinical study
40. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation
41. Relationship among dietary constituents and specific serum clinical components of subjects eating self-selected diets
42. Vitamin C and cardiovascular disease: A review
43. Can anti-oxidants prevent ischaemic heart disease?
44. The effect of high-dose ascorbate supplementation on plasma lipoprotein(a) levels in patients with premature coronary heart disease
45. Ambulatory blood pressure and heart rate responses to vegetarian meals
46. Vegetarian diet, blood pressure and cardiovascular risk
47. A clinical trial of the effects of dietary patterns on blood pressure
48. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects
49. Treatment of hypertension with ascorbic acid
50. Blood pressure, dietary fats, and antioxidants
51. Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables
52. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
53. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels
54. Vitamin E deficiency and enhanced platelet function: Reversal following E supplementation
55. Vitamin E: More than an antioxidant
56. Effects of antioxidant supplementation on platelet function: A randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status
57. α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism
58. Basic research in antioxidant inhibition of steps in atherogenesis
59. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis
60. Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: A prospective study
61. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
62. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
63. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina
64. Schützen antioxidantien vor myokardinfarkt?
65. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels
66. Ascorbate and malondialdehyde in stroke patients
67. Serum tocopherols and lipids in patients with coronary artery disease
68. Antioxidants in adipose tissue and risk of myocardial infarction. The EURAMIC study
69. Lycopene and myocardial infarction risk in the EURAMIC study
70. Lower ischemic heart disease incidence and mortality among vitamin supplement
71. Dietary antioxidants and risk of myocardial infarction in the elderly: The Rotterdam study
72. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women
73. Vitamin E consumption and the risk of coronary disease in men
74. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
75. Dietary vitamin C and β-carotene and risk of death in middle-aged men
76. Dietary flavonoids, antioxidant vitamins and incidence of stroke
77. Carotenoids, vitamins C and E, and mortality in an elderly population
78. Alcohol, fish, fibre and antioxidant vitamins intake do not explain population differences in coronary heart disease mortality
79. Vitamin E consumption and the risk of coronary disease in women
80. Dietary antioxidants and death from coronary heart disease in postmenopausal women
81. Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly
82. The validity of self-reported energy intake as determined using the doubly labelled water technique
83. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
84. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease
85. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
86. Lack of effect on long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease
87. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
88. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
89. Vitamin E: The evidence for an antiatherogenic role
90. α-tocopherol, an effective inhibitor of platelet adhesion
91. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart study
92. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial)
93. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
94. Vitamin E for intermittent claudication (Cochrane Review)
95. Randomized controlled trial of antioxidants in intermittent claudication
96. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
97. Role of antioxidant vitamins in prevention of diseases. Meta-analysis seems to exclude benefit of vitamin C supplementation
98. The antioxidant vitamins and cardiovascular disease
99. Did the antioxidant trials fail to validate the oxidation hypothesis?
100. The dual roles of nutrients as antioxidants and prooxidants: Their effects on tumor cell growth
101. Antioxidant and prooxidant properties of carotenoids
102. High-dose vitamin C: A risk for persons with high iron stores?
103. Health and dietary characteristics of supplement users in an elderly population
104. Plasma antioxidants and lipid peroxidation in acute myocardial infarction and thrombosis
105. Vitamin E supplements and coronary heart disease
106. Vitamin C status and other nutritional indices in patients with stroke and other acute illnesses: A case-control study
107. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene
108. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke respectively: 12 Year follow-up of the Prospective Basel Study
109. Diet and coronary heart disease: A case-control study in Athens, Greece
110. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris
111. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction?
112. Serum levels of antioxidant vitamins in relation to coronary artery disease: A case-control study of Koreans
113. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients
114. Niveles plasmaticos de vitaminas A y E y riesgo de infarto agudo de miocardio
115. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls
116. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women
117. Antioxidant status and alfa-1-antiproteinase activity in subarachnoid hemorrhage patients
118. Association between beta-carotene and acute myocardial infarction depends on polyunsaturated fatty acid status
119. Prospective association between lipid soluble antioxidants and coronary heart disease in men
120. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: The role of α-carotene and β-tocopherol
121. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective study
122. Diet and incident ischaemic heart disease: The Caerphilly study
123. Serum carotenoids and coronary heart disease
124. Dietary vitamin C, beta-carotene and 30-year risk of stroke: Results from the Western Electric study
125. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people
126. Cognitive impairment and mortality in a cohort of elderly people
127. Mortality associated with low plasma concentration of beta-carotene and the effect of oral supplementation
128. Vitamin E deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland
129. Prospective evaluation of dietary and other predictors of fatal stroke in Shanghai, China
130. Do nutritional supplements lower the risk of stroke or hypertension?
131. Effects of vitamin E and beta-carotene on the incidence of primary nonfatal myocardial infection and fatal coronary heart disease
132. Vitamin A and cancer prevention II: Comparison of the effects of retinol and β-carotene
133. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
134. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischaemic attacks
135. Randomised trial of alfa-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
136. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
137. Antioxidants and heart disease: Epidemiology and clinical evidence
138. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)
139. Effects of alpha-tocopherol and beta-carotene supplements on symptoms, progression, and prognosis of angina pectoris
140. Propucol and multivitamins in the prevention of restenosis after coronary angioplasty
141. Vitamin E supplementation and cardiovascular events in high-risk patients
142. Effects of ramipril and vitamin E on atherosclerosis
143. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
144. MRC/BHF Heart Protection study of cholesterol-lowering therapy and of antioxidant vitamins supplementation in a wide range of patients at increased risk of coronary heart disease death: Early safety and efficacy experience
145. Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view
146. Antioxidants and the prevention of coronary heart disease
147. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods
148. Background and rationale behind the SU.VI.MAX study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers
149. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The SU.VI.MAX study-design, methods, and participant characteristics
150. Design of Physicians' Health study II - A randomized trial of beta-carotene, vitamins E and C, and multivitamins in prevention of cancer, cardiovascular disease, and eye disease, a review of completed trials